It pays to diversify your portfolio.
News & Analysis: GlaxoSmithKline
Which stock wins in this big-pharma matchup?
It looks like 2019's going to be much better than expected for these giants operating in different corners of the healthcare sector.
The gene-editing approach might prove more useful outside the clinic.
Which stock wins in a matchup between these two big drugmakers?
Which of these top dividend-paying pharma stocks is the better buy right now?
Looking for stocks that pay you back? Here are three you can add to your list today.
Should investors buy into GlaxoSmithKline's turnaround story?
GSK earnings call for the period ending March 31, 2019.
These three biotech stocks are worth buying this month.